← Evidence map

ReviewTherapeutic advances in respiratory disease2017

Reslizumab in the treatment of inadequately controlled asthma in adults and adolescents with elevated blood eosinophils: clinical trial evidence and future prospects.

Jorge MásperoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 28683596